Benjamin F. Edwards & Company Inc. Has $439,000 Position in Xylem Inc. (NYSE:XYL)

Benjamin F. Edwards & Company Inc. boosted its position in shares of Xylem Inc. (NYSE:XYL) by 98.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 3,836 shares of the industrial products company’s stock after purchasing an additional 1,899 shares during the quarter. Benjamin F. Edwards & Company Inc.’s holdings in Xylem were worth $439,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of XYL. Morgan Stanley lifted its stake in shares of Xylem by 11.5% during the third quarter. Morgan Stanley now owns 4,528,905 shares of the industrial products company’s stock valued at $412,267,000 after acquiring an additional 466,911 shares during the period. Invesco Ltd. boosted its stake in shares of Xylem by 35.1% in the 3rd quarter. Invesco Ltd. now owns 4,182,821 shares of the industrial products company’s stock valued at $380,762,000 after purchasing an additional 1,086,102 shares during the last quarter. Royal Bank of Canada grew its position in shares of Xylem by 10.6% during the 3rd quarter. Royal Bank of Canada now owns 3,408,200 shares of the industrial products company’s stock worth $310,249,000 after buying an additional 327,383 shares during the period. Baillie Gifford & Co. raised its stake in shares of Xylem by 2.3% during the fourth quarter. Baillie Gifford & Co. now owns 3,066,639 shares of the industrial products company’s stock worth $350,701,000 after buying an additional 69,619 shares during the last quarter. Finally, Northern Trust Corp lifted its holdings in Xylem by 4.0% in the third quarter. Northern Trust Corp now owns 2,617,441 shares of the industrial products company’s stock valued at $238,266,000 after buying an additional 100,728 shares during the period. 87.96% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have commented on XYL. Mizuho lifted their target price on shares of Xylem from $110.00 to $135.00 and gave the stock a “neutral” rating in a report on Friday, May 3rd. BNP Paribas began coverage on shares of Xylem in a research report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 price target on the stock. Stifel Nicolaus boosted their target price on Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th. Robert W. Baird raised their target price on shares of Xylem from $151.00 to $155.00 and gave the stock an “outperform” rating in a report on Friday, May 3rd. Finally, Oppenheimer upped their price target on shares of Xylem from $142.00 to $147.00 and gave the company an “outperform” rating in a report on Friday, May 3rd. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $140.70.

Insider Buying and Selling at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares in the company, valued at approximately $360,682.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.27% of the company’s stock.

Xylem Trading Up 0.8 %

NYSE XYL opened at $141.20 on Thursday. The stock has a market capitalization of $34.23 billion, a price-to-earnings ratio of 50.25, a PEG ratio of 2.59 and a beta of 1.08. The stock’s 50 day moving average price is $129.51 and its two-hundred day moving average price is $116.38. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.22 and a current ratio of 1.67. Xylem Inc. has a 52 week low of $87.59 and a 52 week high of $141.30.

Xylem (NYSE:XYL) last released its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 EPS for the quarter, beating the consensus estimate of $0.84 by $0.06. The firm had revenue of $2.03 billion for the quarter, compared to analysts’ expectations of $2 billion. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The business’s quarterly revenue was up 40.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.72 EPS. As a group, analysts anticipate that Xylem Inc. will post 4.24 earnings per share for the current fiscal year.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.